市場調查報告書
商品編碼
1529748
癲癇監測設備市場規模、佔有率、趨勢分析報告:按產品、最終用途、按地區、細分市場預測,2024-2030 年Epilepsy Monitoring Devices Market Size, Share & Trends Analysis Report By Product (Wearable Devices, Conventional Devices), By End-use (Neurology Centers, Diagnostic Centers), By Region, And Segment Forecasts, 2024 - 2030 |
癲癇監測設備的市場趨勢
2023年全球癲癇監測設備市場規模預估為5.59億美元,預估2024年至2030年複合年成長率為6.6%。該市場受到多種因素的推動,例如癲癇盛行率的增加、技術進步、門診監測需求的增加、穿戴式裝置的使用增加以及政府舉措的增加。
此外,對改善診斷和治療的需求不斷增加、市場競爭加劇以及遠端醫療的重要性日益增加也是推動市場成長的關鍵因素。全世界範圍內癲癇的盛行率正在增加,全世界有相當多的人受到影響。
據世界衛生組織 (WHO) 稱,癲癇是一種神經系統疾病,影響全球約 5,000 萬人,使其成為全球最常見的慢性疾病之一。根據該報告,大約 80% 的癲癇患者生活在低收入和中等收入國家 (LMIC),這些國家獲得優質醫療保健的機會往往有限。癲癇的特徵是反覆發作,嚴重影響患者的生活品質。癲癇的有效診斷和治療需要先進的監測設備來即時檢測和追蹤癲癇發作。
光是在美國,估計就有超過 300 萬人患有癲癇症。此外,根據美國疾病管制與預防中心的數據,到 2021 年,約有 290 萬 18 歲及以上的美國成年人報告患有活動性癲癇。
穿戴式科技和資料分析的進步徹底改變了癲癇監測設備領域。採用配備癲癇偵測演算法的智慧型手錶和健身追蹤器,可連續監測患者的生理資料,包括心率、運動和皮膚電活動。這使得能夠即時檢測潛在的癲癇發作,為患者和醫療保健提供者提供及時、準確的資訊,以便做出有關治療和管理的明智決策。例如,2024年2月,連續、非侵入性、不引人注目的神經系統疾病監測先驅Empatica Inc.宣布推出EpiMonitor。這款穿戴式癲癇監測解決方案的最新創新專為成人和 6 歲及以上兒童設計,採用最尖端科技,為癲癇檢測和管理提供無與倫比的便利性和準確性。
此外,政府加強對癲癇研究的資助和投資等措施預計也將在預測期內促進市場成長。例如,英國癲癇研究所宣布,英國政府已透過醫學研究慈善機構早期職業研究人員支持基金向英國癲癇研究所投入超過 189 萬美元的津貼。該慈善機構在 2022-23 年收到了 135 萬美元,在 2021-22 年收到了 562,010.5 美元。此外,2024年3月,英國癲癇協會宣布將投資4,866萬美元用於癌症、失智症和癲癇的研究。
癲癇監測設備全球市場細分報告
該報告預測了全球、區域和國家層面的收益成長,並提供了2018年至2030年各子區隔的最新行業趨勢分析。在這項研究中,Grand View Research, Inc. 根據產品、最終用途和地區對全球癲癇監測設備市場報告進行了細分。
Epilepsy Monitoring Devices Market Trends
The global epilepsy monitoring devices market size was estimated at USD 559.0 million in 2023 and is projected to grow at a CAGR of 6.6% from 2024 to 2030. The market is driven by several factors, such as the increasing prevalence of epilepsy, advances in technology, growing demand for ambulatory monitoring, rising use of wearable devices, and growing government initiatives.
Further, the increasing need for improved diagnosis and treatment, growing competition, and growing importance of telemedicine are also some of the primary factors fueling the market growth. The prevalence of epilepsy is increasing globally, with a significant number of people affected worldwide.
Epilepsy is a neurological disorder that affects an estimated 50 million people worldwide, making it one of the most common chronic conditions globally, according to the World Health Organization (WHO). According to the same report, around 80% of people with epilepsy live in low- and middle-income countries (LMIC), where access to quality healthcare is often limited. The condition is characterized by recurring seizures, which can have a significant impact on a person's quality of life. Effective diagnosis and treatment of epilepsy require advanced monitoring devices that can detect and track seizures in real-time.
In the U.S. alone, over 3 million individuals are estimated to be living with epilepsy. Further, in 2021, about 2.9 million U.S. adults 18 and older reported having active epilepsy, as per the U.S. Centers for Disease Control and Prevention.
The advancement of wearable technology and data analytics has revolutionized the field of epilepsy monitoring devices. The introduction of smartwatches and fitness trackers equipped with seizure detection algorithms has enabled the continuous monitoring of a patient's physiological data, including heart rate, movement, and electrodermal activity. This allows for detecting potential seizure episodes in real-time, providing patients and healthcare providers with timely and accurate information to make informed decisions about treatment and management. For instance, in February 2024, Empatica Inc., a pioneering company in continuous, non-invasive, and discreet monitoring for neurological conditions, announced the launch of EpiMonitor. This latest innovation in wearable epilepsy monitoring solutions is designed for adults and children aged 6 and above, offering cutting-edge technology that provides unparalleled convenience and accuracy in detecting and managing seizures.
Furthermore, growing government initiatives such as funding and investments for epilepsy research are expected to fuel the market's growth over the forecast period. For instance, Epilepsy Research Institute UK announced that the UK government has invested over USD 1.89 million in grant funding into Epilepsy Research UK through its Medical Research Charities Early Career Researchers Support Fund. The charity received USD 1.35 million in 2022-23 and USD 562,010.5 in 2021-22. Further, in March 2024, the British Epilepsy Association announced a USD 48.66 million investment into research for cancer, dementia, and epilepsy.
Global Epilepsy Monitoring Devices Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global epilepsy monitoring devices market report based on product, end-use, and region:
U.S.
Canada
Mexico
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Japan
China
India
Australia
South Korea
Thailand
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait
List of Figure
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Epilepsy monitoring devices market: market outlook
Fig. 14 Epilepsy monitoring devices competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Epilepsy monitoring devices market driver impact
Fig. 20 Epilepsy monitoring devices market restraint impact
Fig. 21 Epilepsy monitoring devices market strategic initiatives analysis
Fig. 22 Epilepsy monitoring devices market: Product movement analysis
Fig. 23 Epilepsy monitoring devices market: Product outlook and key takeaways
Fig. 24 Wearable devices market estimates and forecast, 2018 - 2030
Fig. 25 Conventional devices market estimates and forecast, 2018 - 2030
Fig. 26 Epilepsy monitoring devices market: End use movement analysis
Fig. 27 Epilepsy monitoring devices market: End use outlook and key takeaways
Fig. 28 Hospitals & clinics market estimates and forecasts,2018 - 2030
Fig. 29 Ambulatory surgical centers market estimates and forecasts,2018 - 2030
Fig. 30 Neurology centers market estimates and forecasts,2018 - 2030
Fig. 31 Diagnostic centers market estimates and forecasts, 2018 - 2030
Fig. 32 Global Epilepsy monitoring devices market: Regional movement analysis
Fig. 33 Global Epilepsy monitoring devices market: Regional outlook and key takeaways
Fig. 34 Global Epilepsy monitoring devices market share and leading players
Fig. 35 North America market share and leading players
Fig. 36 Europe market share and leading players
Fig. 37 Asia Pacific market share and leading players
Fig. 38 Latin America market share and leading players
Fig. 39 Middle East & Africa market share and leading players
Fig. 40 North America, by country
Fig. 41 North America
Fig. 42 North America market estimates and forecasts, 2018 - 2030
Fig. 43 U.S. key country dynamics
Fig. 44 U.S. market estimates and forecasts, 2018 - 2030
Fig. 45 Canada key country dynamics
Fig. 46 Canada market estimates and forecasts, 2018 - 2030
Fig. 47 Mexico key country dynamics
Fig. 48 Mexico market estimates and forecasts, 2018 - 2030
Fig. 49 Europe
Fig. 50 Europe market estimates and forecasts, 2018 - 2030
Fig. 51 UK key country dynamics
Fig. 52 UK market estimates and forecasts, 2018 - 2030
Fig. 53 Germany key country dynamics
Fig. 54 Germany market estimates and forecasts, 2018 - 2030
Fig. 55 France key country dynamics
Fig. 56 France market estimates and forecasts, 2018 - 2030
Fig. 57 Italy key country dynamics
Fig. 58 Italy market estimates and forecasts, 2018 - 2030
Fig. 59 Spain key country dynamics
Fig. 60 Spain market estimates and forecasts, 2018 - 2030
Fig. 61 Denmark key country dynamics
Fig. 62 Denmark market estimates and forecasts, 2018 - 2030
Fig. 63 Sweden key country dynamics
Fig. 64 Sweden market estimates and forecasts, 2018 - 2030
Fig. 65 Norway key country dynamics
Fig. 66 Norway market estimates and forecasts, 2018 - 2030
Fig. 67 Asia Pacific
Fig. 68 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 69 China key country dynamics
Fig. 70 China market estimates and forecasts, 2018 - 2030
Fig. 71 Japan key country dynamics
Fig. 72 Japan market estimates and forecasts, 2018 - 2030
Fig. 73 India key country dynamics
Fig. 74 India market estimates and forecasts, 2018 - 2030
Fig. 75 Australia key country dynamics
Fig. 76 Australia market estimates and forecasts, 2018 - 2030
Fig. 77 South Korea key country dynamics
Fig. 78 South Korea market estimates and forecasts, 2018 - 2030
Fig. 79 Thailand key country dynamics
Fig. 80 Thailand market estimates and forecasts, 2018 - 2030
Fig. 81 Latin America
Fig. 82 Latin America market estimates and forecasts, 2018 - 2030
Fig. 83 Brazil key country dynamics
Fig. 84 Brazil market estimates and forecasts, 2018 - 2030
Fig. 85 Argentina key country dynamics
Fig. 86 Argentina market estimates and forecasts, 2018 - 2030
Fig. 87 Middle East and Africa
Fig. 88 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 89 South Africa key country dynamics
Fig. 90 South Africa market estimates and forecasts, 2018 - 2030
Fig. 91 Saudi Arabia key country dynamics
Fig. 92 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 93 UAE key country dynamics
Fig. 94 UAE market estimates and forecasts, 2018 - 2030
Fig. 95 Kuwait key country dynamics
Fig. 96 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 97 Market share of key market players- Epilepsy monitoring devices market